UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA FACULTY OF GENERAL MEDICINE DOCTORAL THESIS SUMMARY
|
|
- Daisy Stafford
- 5 years ago
- Views:
Transcription
1 UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA FACULTY OF GENERAL MEDICINE DOCTORAL THESIS SUMMARY CLINICAL AND PARACLINICAL CORRESPONDENCES IN EPITHELIAL TUMORS OF THE OVARY Thesis Coordinator, Prof. Univ. Dr. NICOLAE RÂCĂ Doctoral Student, LORENA DIJMĂRESCU CRAIOVA
2 TABLE OF CONTENTS PART I. STATE OF KNOWLEDGE CHAPTER 1. OVARY - BETWEEN NORMALITY AND PATHOLOGY 1.1. INTRODUCTION EPIDEMIOLOGY ETIOLOGY AND RISK FACTORS ETIOLOGICAL MECHANISMS OF OVARIAN CARCINOGENESIS CELLULAR MECHANISMS OF CARCINOGENESIS... 9 CHAPTER 2. STRUCTURE AND INFRASTRUCTURE OF NON TUMORAL AND TUMORAL OVARIAN LESIONS 2.1. Histological classification of ovarian tumors Stromal and follicular non - tumoral modifications Tumoral lesions CHAPTER 3. POSITIVE DIAGNOSIS OF OVARIAN TUMORS 3.1. Anamnesis and clinical diagnosis Paraclinical diagnosis Imagistic examination Immunological diagnosis Histopathology and immunohistochemistry of ovarian tumors CHAPTER 4. MALIGNANCY SCORES APPLIED TO OVARIAN PATHOLOGY 4.1. OCSI - Ovarian Cancer Symptom Index RMI Risk malignancy index OVA ROMA (Risk of Ovarian Malignancy Algorithm)... 42
3 II. SPECIAL PART CHAPTER 5. PREREQUISITES, OBJECTIVES AND HYPOTHESIS OF THE DOCTORAL THESIS 5.1. SCOPE AND OBJECTIVES OF THE STUDY MATERIAL AND METHOD Clinical and ultrasound evaluation Immunology study Classification of patients per risk groups through the calculation of malignancy scores Histological and immunohistochemistry study Statistical processing of data CHAPTER 6. CLINICAL STUDY. STATISTICAL ANALYSIS 6.1. General data of the study groups General features of the group to be studied Clinical study on the ovarian pathology CHAPTER 7. ULTRASOUND STUDY IN THE DIAGNOSIS OF OVARIAN LESIONS 7.1. Clinical ultrasound study Ultrasound and histopathological correlations Statistical analysis Results of the statistical analysis for the Sassone ultrasound score Results of the statistical analysis for the value of velocimetry indices Evolution of ovarian lesions upon menopause CHAPTER 8. IMMUNOLOGY STUDY IN THE DIAGNOSIS OF OVARIAN LESIONS 8.1. Use of tumoral biomarkers Use of CA125 and HE4 in pre-surgery evaluation of the adnexal tumor masses Correlations of the CA125 and HE4 levels with the type of histopathological lesion Statistical analysis Results of the statistical analysis for CA Results of the statistical analysis for HE
4 8.3. Serological analysis of the intracystic fluid CHAPTER 9. HISTOPATHOLOGY AND IMMUNOHISTOCHEMISTRY DIAGNOSIS OF OVARIAN LESIONS 9.1. Histopathological study of ovarian tumors Immunohistochemistry diagnosis of ovarian tumors CHAPTER 10. ULTRASOUND, SEROLOGICAL AND HISTOPATHOLOGICAL CORRELATIONS IN THE DIAGNOSIS OF OVARIAN LESIONS Classification of patients in a group of risk by using the RMI score Use of RMI in pre-surgery evaluation of an ovarian tumoral mass RMI diagnosis correlations with the type of histopathological lesion Results of the statistical analysis for the RMI Score Study on the diagnosis correlation between the HE4 serum marker and the ROMA Algorithm with ovarian lesions Use of the ROMA Algorithm in pre-surgery evaluation of ovarian tumoral masses Correlations of values obtained through the ROMA Algorithm with results of the histopathological examination Results of the statistical analysis for the ROMA Algorithm DISCUSSIONS CONCLUSIONS BIBLIOGRAPHY
5 KEYWORDS Ovarian lesions, progressive ovarian lesions, ovarian cancer, early diagnosis, ultrasound score, MRI, HE4, ROMA Algorithm INTRODUCTION Found on the border between disciplines, disputed by endocrinologists, anatomic-pathologists, and gynaecologists, the part that represents, in the happiest event, only 0.01% of the weight of a woman, is still a great unknown, despite the expansion of biomedical science and technique. Screening for ovarian cancer is a challenge for clinicians, it is an insufficiently explored subject on national level, and internationally, although there have been set a number of criteria, results are still quite controversial and incompletely studied. An early pre-surgery diagnosis, by non-invasive methods of the benign/malignant nature of the adnexial masses, that would facilitate the choice of an optimal therapeutic stance, which includes also the conservative attitude, is necessary as a very important aspect is the incidence of these formations during the reproductive period. Pathogenesis of the ovarian carcinoma is not known due to the lack of a progression model of the tumor. Based on a review of the most recent clinical-pathological and molecular studies, surface epithelial neoplasia is divided into two broad categories: type I and type II, which correspond to the two main tumorigenesis paths. Tumors of the type I include lower-grade malignant tumors, occurring in a progressive manner from boundary tumors, and tumors of type II, which include high-grade malignant tumors and for which the precursor morphological lesions have not been identified, the so-called "de novo" development tumors [17,18,34]. In Romania, ovarian cancer is the third cause of death by malignant pathology, holding the fifth position, after the incidence of breast cancer, cervical, colorectal and lung cancers. The worldwide incidence of ovarian cancer is 2%, and in Romania it reaches 4.6% [153]. Alarming results for our country are probably due both to non-existent or inoperative screening programs and to the lack of management on the prevention of these diseases and their early detection. The polymorphism of ovarian tumors has an embryo-genetic, histological, clinical and progressive substrate, fact that explains the difficulties of classification, lack of consensus. From the embryology perspective, the ovary is a mosaic of differentiated tissues (wrapp ing epithelium, ovarian stroma, conjunctive tissue, vessels, nerves, lymphatic) and non-differentiated (cells and vestiges of the Wol ff channels, cells with phase antigen derived from the three embryonic foils/ectoderm, endoderm, mesoderm). Ovarian cancer symptoms are related to the presence of an adnexial part and are often vague and non-specific. The main diagnosis objective of assessing such a formation is to determine whether it is benign or malignant. It is estimated that 5-10% of women go for a surgical procedure for a suspicion of ovarian cancer, which is confirmed in % of the cases. Considering that the majority of adnexial
6 formations are benign, it is very important to be able to determine before the surgery if a patient shows an increased risk of ovarian cancer, in order to approach an appropriate therapeutic stance. Owing to the desire and the need to identify a possible resolution of the problems posed by the complex appearance of the tumoral ovary, the incidence of which is increased during the reproductive and post-menopause period, I considered necessary to deepen the clinical-therapeutic inter-relations and physiological, pathophysiological, histopathology and immunohistochemistry aspects through the preparation of the paper herein, with the title Clinical and paraclinical correspondences in epithelial tumors of the ovary. The complexity and importance of the themes explored guided me in my intention to carry out a detailed study in this direction, because the diagnosis overvaluation is frequent, and the impact of noslogical classification as well as the inter-relation with the quality of life of women (post-surgery status and loss of the reproductive potential) represent a major concept that must be heeded. The scope pursued was to specify the correlation between early diagnosis of ovarian cancer, postsurgery, according to morphological and histological appearance, but also pre-surgery, with malignancy scores through the use of tumoral markers with a high level of sensitivity and specificity. The objectives proposed to be achieved are as follows: Pathophysiological implications and practical implications of the risk factors and nontumoral ovarian lesions The correlation between the degree of the ovarian lesion and the early diagnosis, highlighted by the use of malignancy scores (symptomatic, ultrasound and serum) Correlation between different ultrasound parameters with an early diagnosis and standardization of an ultrasound examination Correlation between cutt-of values of the tumoral markers with the histopathological appearance of the ovarian lesion. MATERIAL AND METHOD In addressing this task, I performed a study carried out on a group 329 patients with adnexial tumor formations, examined and treated in the period from January 2005 to March The study was carried out at the Obstetrics-Gynaecology Clinic of the Filantropia Clinical Municipal Hospital and the Emergency Clinical County Hospital of Craiova, the patients being evaluated by ultrasound and serologically, and classified in a group of risk which led to the establishment of the therapeutic protocol with or without surgery, completed with obtaining the histopathological data. There were selected patients with ages between 19 and 71 years who showed adnexial tumor formations, diagnosed by clinical and ultrasound means in the Gynaecology service, but also other specializations (gastroenterology and internal medicine) by non-specific abdominal symptoms. Ultrasound aspects of inclusion in the group were represented by the appearance of suspicious ultrasound images. A
7 postulate of ultrasound examination for ovaries is noted, namely that the ovary which is not visible from the ultrasound perspective is considered to be normal. During the period mentioned, patients under study, by filling out the selection file and signing of an informed consent, have undergone an investigative protocol establishing the set of quantifiable parameters, specific to cases tracking. There was considered the clinical and serological evaluation, the management adjusted to each case being prepared subsequently. The personal study is emphasized on the following subchapters: Clinical and ultrasound evaluation Immunological study Classification of patients within risk groups, by calculating the malignant risk index MRI ROMA Histology and immunohistochemistry study Statistical processing of data RESULTS Following the clinical study performed, the breakdown by age group reveals a higher incidence in the age group of years, 121 cases (36.7%) and years, 76 cases (23.1%), namely during the fertile period of women. The higher rate of occurrence correlates in the age periods with both a more detailed investigation into the breeding programmes, but also with a more frequent infections pathology, by early start of the sexual life, sexual transmission diseases, multiple partners. Per the study performed, I noticed that these epidemiological associations, due to low sensitivity and weak positive predictive value, cannot be implemented with a screening value, for the purpose of early diagnosis of ovarian cancer, as there cannot be outlined a phenotype of the patient with ovarian pathology. Following the histopathology and immunohistochemistry study I found that, out of all 122 cases with the clinical diagnosis of ovarian tumor, pseudotumors represented only 19,67% of the cases, the casuistic being dominated by proper ovarian tumors which accounted for over 80% of the cases. With pseudotumors, there were diagnosed histological lesions of type: follicular, lutein cysts, ovarian fibromatosis and the policystic ovary syndrome, the most widely represented being the follicular and lutein cysts (66.66% of pseudotumors). In regards to the pre-surgery diagnosis of ovarian tumors, following the ultrasound study, a percentage of 15.5% of cases with the ovary of more than 10 cm in size was diagnosed by ultrasound and correlated with the histopathological examination of malignant lesion. For tumoral masses of less than 10 cm, the percentage of correct diagnosis of malignant lesion was of about 5%, which reveals that even though it is the most reliable ultrasound feature, it is also the least specific one. In the literature, it is considered that an ovarian volume under 20 cm3, in women at pre-menopause, and under 10cm3 in women at post-menopause is associated with a decreased risk of malignancy [26, 61].
8 Making the ROC curve for the Doppler ultrasound score showed a sensitivity of and specificity of for this prediction score, with a limit of 0.4 to PI, this limit being useful in the prognostic usage of the score value for the probability of malignancy. Following the immunological study regarding CA 125 I found that it has made a major contribution in the management of patients with benign or malignant adnexial tumors. The use of the CA 125 serum level in the pre-surgery evaluation of adnexial tumor masses cannot be used as a single tool for the prediction of malignancy. It can be used as an indicator of sensitivity for the progression and recurrence of the neoplasic disease, when its serum levels correlate with an ultrasound diagnostic, which increases the ability to distinguish between benign and malignant ovarian pathology. The positive predictive value of CA 125 was 94% for women in post-menopause, with a negative predictive value of 80%, with no statistical differences in correlation with other studies. For patients in pre-menopause, CA 125 had a sensitivity of 85%, with specificity of 88% and a positive predictive value of 83%. However, considering that the sub-evaluation was 0%, we can say that, normal levels of the serum marker represent a definite prediction factor for ovarian non-malignant lesions. Through making the ROC curve, I have also established the sensitivity and specificity, when the MRI score takes on different values, noticing a sensitivity of and specificity of 0.859, as useful prognostic limits the use of the MRI score for the probability of malignancy. HE4 levels are increased in more than 50.0% of the cases where CA125 is not expressed; results of the combined test have a sensitivity and specificity greater than the CA125 as a single marker; correlation with histopathological findings show that CA125 and HE4 or HE4 alone has a higher sensitivity to patients with ovarian cancer; as a single marker HE4 was more sensitive than CA125; the combination of HE4 and CA125 was more sensitive than a single marker. I found that HE4 and ROMA have displayed the best diagnostic performance. HE4 in statistical analysis has shown a sensitivity and specificity of 0.950, respectively, as useful limits in the prognostic usage of the HE4 value for the probability of malignancy. CONCLUSIONS 1. The early diagnosis of ovarian cancer is still a challenge to modern medicine. Evaluation of adnexial masses constitutes a continuous progressive problem worldwide, with a multidisciplinary approach: gynaecological, oncological, immunological, histopathological, imaging, as structured in the international scientific specialized events. 2. In recent years, there has been an explosion of important progresses in biomedical engineering, but at the moment, there is no biomarker with a 100% sensitivity and specificity for the precise detection of early stage epithelial ovarian cancer.
9 3. CA-125: Is not an ideal serum biomarker for the presence of ovarian cancer. CA-125 does not have a sufficient sensitivity or a high specificity to justify its use as a unique screening marker for ovarian cancer. 4. Single biomarker for detection testing: mission impossible? The discovery of specific markers is very difficult. The three major obstacles are molecular heterogeneity between tumors, prevalence of noncancerous diseases that reduces the specificity of the biomarker and production and its low concentration especially for the early stage of the disease where cancerous lesions are minimal. 5. Patients diagnosed with an ovarian disease, enrolled in the original study (329) have been carefully assessed after completing specific screening sheets and guided towards conservative or surgical therapy ( %). Rigorous selection of the patients undergoing ovarian exeresis was confirmed by follow-up of these cases: over the five years of personal research, resulting in no patient of the group under study presented signs of potentially evolutionary ovarian pathology. 6. The study of the selection files outlines the idea that ovarian tumor pathology is more common in the population segment with ages overlapping with the reproductive period, especially in urban areas, while the malignant pathology is the preserve of the 5th or 6th decade of life. Before the serological and sonographic diagnosis, it is necessary to establish particular features, related to the various variables: age, origin, menstrual status, pregnancy status, diet habits, smoking, infectious pathology, which can include the patient in a risk group. 7. The personal study defines the endocrine-social profile of the patients that may develop an ovarian lesion with surgical indication, during a certain stage of life and which, in particular, should be subject to supported gynaecological examinations: patient in the reproductive period with menstrual disorders, with ovarian volume increased, CA125 increased. 8. Ovarian disorders clinic. For the age group of years, lack of pelvi-abdominal pains and symptomatology predominate, in relation to the inflammatory phenomena. Irregular bleeding appears especially in the age group of years, i.e. pre-menopause, being perhaps associated with preclimax menometroragy which have necessitated a closer investigation. Urinary and digestive disorders are mostly the preserve of menopause. 9. From the histopathological point of view, ovarian lesions constellation was dominated by benign lesions (%). The maximum incidence of tumors in the surface epithelium of the 5th decade for benign forms, and in the 6th decade for malignant forms suggests the possible transition from benign to malignant. In addition, the presence within the same tumor of borderline and malignant or benign aspects, argues this evolutionary possibility from benign to malignant, passing through the borderline state. 10. Immunohistochemistry. For a proper diagnosis, some poorly differentiated malignant serum tumors require complementary immunohistochemistry investigations with the help of a panel of antibodies including CK7, CK 20, CA125, CEA, estrogen and progesteron receptors and oncoprotein p53.
10 11. 3D ultrasound allows complex analysis of the ovarian formations structure, in some cases being able to replace computerized tomography. Values of the vascular parameters 3D-PD seem to be a promising tool for the prediction of ovarian cancer in complex vascularized adnexial masses. 12. The positive predictive value of CA 125 was of 94% for women in post-menopause, with a negative predictive value of 80%, without existing statistical differences in correlation with other studies. For patients in pre-menopause, CA125 detection had a sensitivity of 85%, with specificity of 88% and a positive predictive value of 83%. 13. Making the ROC curve for the Sassone ultrasound score showed us a sensitivity of and specificity of of this prediction score with a limit of 0.4 to PI, this limit being useful in prognostic usage of the score value for the probability of malignancy. 14. MRI. Through making the ROC curve for MRI, I established the sensitivity and specificity; when the MRI score gets various values, there is distinguished a sensitivity of and a specificity as useful prognostic limits of the MRI score values for the probability of malignancy. 15. HE4. ROC curve calculation showed us a sensitivity and specificity of 0.950, respectively, as useful limits in the use of HE4 prognostic value for the probability of malignancy. 16. ROMA is a simple scoring system that gives excellent diagnostics performance for the detection of EOC in post-menopause, but not in pre-menopause. The ROMA - HE4 Algorithm and CA 125 -applied successfully classified 93.8% of the EOC correctly marked as being with high-risk. 17. The combination of increased levels of serum for CA 125 and HE4 correlates with the risk of epithelial ovarian cancer, and an increased level of CA 125, without an increased level of HE4 correlates with a benign condition. An increased level of HE4 and normal CA 125 suggests the presence of another type of cancer (for example, the endometrium type). 18. Transvaginal ultrasound is the most useful in the correct diagnosis of the adnexial masses in post-menopause, viewing the ovaries being difficult for older women, especially if they have a history of hysterectomy or an increased BMI. The presence of ovarian tumors is common in menopause; they have a dynamic evolution, most of them changing the dimensions between 2 successive examinations. 19. Doppler assessment should complement the examination of a tumoral ovary. Sonographic tracking is recommended in the case of simple ovarian cysts, less than 3 cm, surgery being recommended in cases of cysts with large and complex aspect, with modifications of the velocimetry indices. 20. While the sonographic morphological characteristics represent the first criteria for benign/malignant differential diagnostic, the study of the intracystic liquid concerning CA125, E2, P may confirm the diagnosis. The correlation between the serum level and the intracystic level of CA125 with different variations may set accurately the diagnostic. A profile of differential diagnostic of benign/malignant ovarian lesions may be obtained through the combination of these criteria. However, the histopathological confirmation is necessary in most cases.
11 21. The tumoral ovary correctly investigated with the completion of the clinical - paraclinical stages of diagnostic may be subjected to a conservator surveillance protocol in particular for patients who have not completed the family planning. 22. Obtaining new data in terms of quality of life. As a quintessence of these years of study, I have been concerned about the possibilities of improving the quality of life for women with ovarian pathology by explaining the concept of an ovarian lesion, with lowering the impact of notion of ovarian tumor, which is widely used. It is accepted in the literature the term of tumor and non-tumor ovarian lesion. I have also noted the negative impact of the existence of an ovarian tumor during the reproductive period, patients often opting for surgery, before completing the diagnostics platform, even at the risk of not concluding their family planning. 23. The use of a noninvasive means of discrimination among the malignant ovarian masses and the benign lesions is important considering that approximately 20 percent of women will develop an ovarian cyst at some point in their lives. Without adequate means to discern the potential of these malignant tumors, a considerable proportion of these women will be subjected to unnecessary surgery.
12 Curriculum vitae Europass Personal information Surname(s) / First name(s) Address(es) Dijmarescu, Anda Lorena 11, Dezrobirii, Apartment House E 9, Apartment no.3, Craiova, Romania Telephone(s) Cell: Fax(es) (s) lorenadijmarescu@yahoo.com Nationality Romanian Date of birth 10 th of September 1972 Work experience Occupation or position held Main activities and responsibilities Name and address of employer Type of business or sector Dates University Assistant Professor Practical works - normal and pathological obstetrics UNIVERSITY OF MEDICINE AND PHARMACY Faculty of Midwives and Nurses - Craiova. Teaching and research activities: teaching; hours of practical works and seminars; publishing articles in international and specialization magazines and indexed magazines ISI - WEB OF SCIENCE. Dates Occupation or position held Specialist Physician, Obstetrics Gynaecology Main activities and responsibilities Name and address of employer Type of business or sector Education and training Title of qualification awarded Principal subjects/occupational skills covered Name and type of organization providing education and training Level in international classification Title of qualification awarded Clinical practice City Hospital of Strehaia, detached at the University Hospital of Craiova. Clinical practice. Dates Obstetrics Gynaecology Resident Physician Obstetrics Gynaecology University of Medicine and Pharmacy of Craiova Dates DOCTORAL Student in Medicine
13 Principal subjects/occupational skills covered Name and type of organization providing education and training Level in international classification University education Title of qualification awarded Principal subjects/occupational skills covered Name and type of organization providing education and training Level in international classification Specialization Obstetrics - Gynaecology Competency in Reanimation Of The New Born Competency in Ultrasound for Obstetrics - Gynaecology Competency in Colposcopy Module I Hysteroscopy Psycho Pedagogical Module graduated with the thesis University of Medicine and Pharmacy of Craiova Dates BACHELOR DEGREE IN Medicine General Medicine University of Medicine and Pharmacy of Craiova University education Personal skills and competences Mother tongue(s) Romanian Other language(s) Self evaluation Understanding Speaking Writing European level (*) Listening Reading Participation to a conversation English Speech Writing assertion B2 Independent user B2 Independent user B2 Independent user B2 Independent user B2 Independent user French B1 Beginner B1 Beginner B1 Beginner B1 Beginner B1 Beginner Social skills and competences Team spirit, capacity to adjust and effective communication, reliability, dynamic and sociable spirit acquired through professional activity. Competency Ultrasound in Obstetrics and Gynaecology, Colposcopy, Reanimation of the new born, Psycho - Pedagogy Organizational skills and competences Computer skills and competences The ability to engage in teamwork, ability of synthesis and mobilization, optimal management of time, autonomy, initiative, decision-making skills, creativity, dynamism, efficiency. Microsoft Office: Word, Excel, Internet navigation, use of the Blackboard system - elearning type - for evaluation and teaching.
14 ARTICLES PUBLISHED IN MAGAZINES 1. Therapeutic attitude in infertility associated with serum ovary cysts. N. Râcă, Lorena Dijmărescu, Florentina Tănase, OBSTETRICS AND GYNAECOLOGT, SROB - volume 4, no. Supplement, October THE EVOLUTION OF OVARIAN INJURIES IN MENOPAUSE Lorena Dijmarescu*, Carmen Gheta**, Magda Manolea*, Florentina Tanase*, Comanescu A*, Cristina Fota *,Liliana Novac*, CRAIOVA MEDICALĂ 3. DIAGNOSIS CORRELATIONS IN OVARIAN TUMORS Lorena Dijmarescu*, Carmen Gheta**, Florentina Tanase*, Comanescu A*,Magda Manolea*, Liliana Novac*, CRAIOVA MEDICALĂ ARTICLES PUBLISHED IN VOLUMES OF INTERNATIONAL SCIENTIFIC EVENTS RECOGNIZED IN THE FIELD Correlation of the ultrasound appearance of the pseudopolicystic ovary with ureaplasma urealitycum infection, Lorena Dijmărescu, Magda Manolea, S. Cotarcea, D. Plesan, IX International Congress of Medical Sciences, Sofia, Bulgaria,13-16 May 2010 Immunohistochemical variations in case of pregnancy associated with ovarian tumors - case report, L. Dijmarescu, L. Novac, S. Cotarcea, M. Manolea T. Tanase, A. Comanescu, R. Lanoiu,S. Neamtu, S. Cerga X International Congress of Medical Sciences, Sofia, Bulgaria,13-16 May 2010 Study on pre and after surgery diagnosis correlations in ovarian tumors L Dijmarescu, ESGO, Milano, Italia, October 2011 The ovarian medicamentary stimulation Lorena Dijmarescu, N. Raca, Florentina Tanase, V. Gheorman Human Reproduction, Venice, March 10-13, 2005 Study regarding morphological velocimetrical and imunological corelation of ovarian tumor formations, Lorena Dijmarescu, Magda Manolea, Florentina Tanase, Liliana Novac Summary Volume of ESGO, The 15 th International Meeting of the European Society of Gynecological Oncology (ESGO)- Belgrad, Serbia October 2009 Other skills and competences ARTICLES PUBLISHED IN VOLUMES OF NATIONAL SCIENTIFIC EVENTS WITH INTERNATIONAL PARTICIPATION RECOGNIZED Preserving fertility in Oncology N. Râcă, Lorena Dijmărescu, Florentina Tănase- report- the 14 th Congress of Obstetrics and Gynaecology with International Participation Bucharest September 2006 Correlation of the ultrasound appearance of the pseudo-polycystic ovary with the UU infection, Lorena Dijmărescu, Smărăndiţa Cotarcea, Magda Manolea, Raluca Lînoiu, UMF Craiova, Edition XXXX,4-5 June 2010, Craiova Genetic context of the polycystic ovaries syndrome in teenagers, Liliana Novac, Magda Manolea, Lorena Dijmărescu, Lidia Boldeanu, Adela Voican, Smărăndiţa Cotarcea, Raluca Lînoiu, D. Pleşan, 5 th Congress of the Romanian Society of Endocrinological Gynaecology, Sinaia, June 2010 Diagnostics, ultrasound and hormone correlations between SOPC and the micropolycystic ovary, Lorena Dijmărescu, Smărăndiţa Cotarcea, L. Novac, Florentina Tănase, Magda Manolea, Raluca Lînoiu, 15 th National Congress of Obstetrics and Gynaecology, Bucharest, October 2010 Diagnostic correlations in ovarian tumors, Dijmarescu Lorena*, Comanescu A*, Manolea Magda *, Novac Liliana*, Niculescu Mihaela, UMF Craiova, Edition XLI, 3-4 June 2011, Craiova Caesarean surgery - the Misgav Ladach method Dijmărescu Lorena, Voinea B., Roibu Mădălina, Manolea Magda, Novac Liliana, Neaţu Alina, UMF Craiova Edition XXXVIII-a, 6-7 June 2008 Association of bacterial vaginosis with premature birth and the role of screening in vaginal infection for pregnant women Lorena Dijmărescu, T. Grigore, Liliana Novac, Magdalena Manolea, R. Pană, F. Braneţ, Alina Neaţu, Anca Groza, 9 th National Conference of the Romanian Society of Obstetrics-Gynaecology, September 2008 Cluj-Napoca Preliminary study on Hyperemesis gravidarum associated with hypothyroidia before pregnancy L. Dijmărescu, L. Novac, S. Cotarcea, F. Tănase, M. Manolea 6 th Congress of the Romanian Society of Endocrinological Gynaecology with international participation, Sinaia 7-9 Mai 2009 Diagnostics, ultrasound and hormone correlations between SOPC and the micropolycystic ovary, Lorena Dijmărescu, Smărăndiţa Cotarcea, L. Novac, Florentina Tănase, Magda Manolea, Raluca Lînoiu, 15 th National Congress of Obstetrics and Gynaecology, Bucharest, October 2010 Hormonal and ultrasound correlations in early secondary ovarian failure prediction, Lorena Dijmărescu, Smărăndiţa Cotarcea, Magda Manolea, D. Pleşan, Liliana Novac, 5 th Congress of the Romanian Society of Endocrinological Gynaecology, Sinaia, June 2010 Preliminary study on the association of thyroid autoimmune and trombophilia in pregnancies with increased risk, Lorena Dijmărescu, L. Novac, Smărăndiţa Cotarcea, Tănase Florentina, Magda Manolea, D. Pleşan, Medical Days Vasile Dobrovici, Iaşi, Mai 2010 Antenatal factors associated with the syndrome of discordant growth in twins, Lorena Dijmărescu, Novac Liliana, Magdalena Manolea, Voinea B, Pleşan D, UMF Craiova, Edition XXXIX, Craiova, 5-6 June 2009, p.346, verbal presentation, ISSN RESEARCH-DEVELOPMENT-INNOVATION PROJECTS - BASED ON CONTRACT OR GRANT -
15 Annexes PROFESSIONAL AND ACADEMIC SERVICES MEMBERSHIP IN PRESTIGIOUS PROFESSIONAL SOCIETIES IN ROMANIA AND ABROAD Romanian Society of Obstetrics Gynaecology Romanian Society of Endocrinological Gynaecology European society of Gynaecological Oncology SRCMIG
EARLY DIAGNOSIS OF STROKE IN PATIENTS WITH DIABETES MELLITUS
ORADEA UNIVERSITY FACULTY OF MEDICINE AND PHARMACY DOCTORAL THESIS EARLY DIAGNOSIS OF STROKE IN PATIENTS WITH DIABETES MELLITUS AUTHOR BRISC MIHAELA CRISTINA COORDINATOR Prof.Dr.MARIUS MOTOCU CONTENTS
More informationPh.D. THESIS ENDOMETRIAL HYPERPLASIAS IN PERIMENOPAUSE SUMMARY
UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA FACULTY OF MEDICINE Ph.D. THESIS ENDOMETRIAL HYPERPLASIAS IN PERIMENOPAUSE SUMMARY SCIENTIFIC COORDINATOR: PROF. DR. MIHAI B. BRĂILA, Ph.D. Ph.D. Graduand:
More informationSUBSPECIALIST TRAINING PROGRAMME
EUROPEAN BOARD AND COLLEGE OF OBSTETRICIANS AND GYNAECOLOGISTS (EBCOG) AND EUROPEAN SOCIETY OF GYNAECOLOGICAL ONCOLOGY (ESGO) SUBSPECIALIST TRAINING PROGRAMME IN GYNAECOLOGICAL ONCOLOGY This Programme
More informationDOCTORAL THESIS SUMMARY
UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA FACULTY OF MEDICINE DOCTORAL THESIS SUMMARY CLINICO-IMAGING STUDY OF INVASIVE DUCTAL BREAST CARCINOMAS CORRELATED TO HORMONAL RECEPTORS AND HER2/NEU ONCOPROTEIN
More informationWe warmly invite you to work together on improving the quality of the medical act and introducing the standards of colposcopy in our work.
The Romanian Society for Colposcopy and Inferior Genital Tract Pathology already has a tradition of more than one decade. During this time, a number of meetings, lectures and seminars have been held, including
More informationRicu Gabriel. Medical field. Radiotherapy Oncology : Radiation Oncologist PERSONAL INFORMATION
PERSONAL INFORMATION Ricu Gabriel om. Nuci, Sat Micsunestii Mari, Jud. Ilfov, Romania -------- 0040722 3 665 ricugabriel@yahoo.com Sex M Date of birth 6.09.978 Place of birth Bucharest, Romania I Nationality
More informationIs It Time To Implement Ovarian Cancer Screening?
Is It Time To Implement Ovarian Cancer Screening? Prof Dr Samet Topuz Istanbul Medıcal Faculty Department Of Obstetrics and Gynecology ESGO Prevention in Gynaecological Malignancies September 08 2016 Antalya
More informationCurriculum vitae Europass
Curriculum vitae Europass Personal Information Last name / First name ŢUŢU MIHAELA CORINA E-mail mihaela_psi@yahoo.com Nationality Romanian Birth Date August 23 th,1967 Gender Female Visaed working place
More informationDOCTORAL THESIS SUMMARY
UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA DOCTORAL THESIS HISTOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL STUDY OF GASTRIC CARCINOMAS SUMMARY Scientific Coordinator: Univ. Prof. Dr. SIMIONESCU CRISTIANA EUGENIA
More informationADENOMYOSIS. ETIOPHATOGENICAL, DIAGNOSTIC AND THERAPEUTICAL CONSIDERATIONS
UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA FACULTY OF MEDICINE Ph.D. THESIS ADENOMYOSIS. ETIOPHATOGENICAL, DIAGNOSTIC AND THERAPEUTICAL CONSIDERATIONS ABSTRACT SCIENTIFIC COORDINATOR: PROF. DR. MIHAI
More informationAudit changes clinical practice! impact on rate of justification of hysterectomy indication
ecommons@aku Department of Obstetrics & Gynaecology Division of Woman and Child Health August 1995 Audit changes clinical practice! impact on rate of justification of hysterectomy indication Khalid S.
More information3 Summary of clinical applications and limitations of measurements
CA125 (serum) 1 Name and description of analyte 1.1 Name of analyte Cancer Antigen 125 (CA125) 1.2 Alternative names Mucin-16 1.3 NLMC code To follow 1.4 Description of analyte CA125 is an antigenic determinant
More informationRisk of Malignancy Index in the Preoperative Evaluation of Patients with Adnexal Masses among Women of Perimenopausal and Postmenopausal Age Group
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 17, Issue 9 Ver. 8 (September. 2018), PP 20-25 www.iosrjournals.org Risk of Malignancy Index in the Preoperative
More informationOVARIAN CANCER STATISTICS
bioprognos OncoOVARIAN Dx Non-invasive blood test useful to suggest a possible diagnosis in patients with suspected malignancy in the ovarians, reduce inappropriate diagnostic tests, days of hospitalization,
More informationبسم هللا الرحمن الرحيم. Prof soha Talaat
بسم هللا الرحمن الرحيم Ovarian tumors The leading indication for gynecologic surgery. Preoperative characterization of complex solid and cystic adnexal masses is crucial for informing patients about possible
More informationX-Plain Ovarian Cancer Reference Summary
X-Plain Ovarian Cancer Reference Summary Introduction Ovarian cancer is fairly rare. Ovarian cancer usually occurs in women who are over 50 years old and it may sometimes be hereditary. This reference
More informationWhat You Need to Know About Ovarian Cancer
What You Need to Know About Ovarian Cancer About Us The Rhode Island Ovarian Cancer Alliance (RIOCA) was formed in honor and memory of Jessica Morris. Jessica was diagnosed with Stage IIIC Ovarian Cancer
More informationThe 6 th Scientific Meeting of the Asia Pacific Menopause Federation
Abnormal uterine bleeding in the perimenopause Perimenopausal menstrual problems are among the most common causes for family practitioner and specialist referral. Often it is due to the hormone changes
More informationOne of the commonest gynecological cancers,especially in white Americans.
Gynaecology Dr. Rozhan Lecture 6 CARCINOMA OF THE ENDOMETRIUM One of the commonest gynecological cancers,especially in white Americans. It is a disease of postmenopausal women with a peak incidence in
More informationHEALTH SCIENCES CENTER MEDICAL SURGEON
GENERAL OBJECTIVE: Train highly competent surgeons in individual and collective health care, responding to the health care needs of current epidemiological and demographic profiles; In the prevention,
More informationTHE ASSOCIATION OF ETIOLOGICAL FACTORS IN CHRONIC GASTRITIS
THE ASSOCIATION OF ETIOLOGICAL FACTORS IN CHRONIC GASTRITIS Medicine Lucrețiu RADU 1 Mihaela VLADU 2 Diana CLENCIU 3 Anda-Lorena DIJMĂRESCU 4 Marcelina Gabriela MIHAI 5 Cristina Gabriela ENE 6 Tiberiu
More informationThe 6 th Scientific Meeting of the Asia Pacific Menopause Federation
Predicting the menopause The menopause marks the end of ovarian follicular activity and is said to have occurred after 12 months amenorrhoea. The average age of the menopause is between 45 and 60 years
More informationDiscussing Fertility Preservation with Breast Cancer Patients
Chapter 35 Discussing Fertility Preservation with Breast Cancer Patients Jacqueline S. Jeruss J.S. Jeruss (B) Department of Surgery, Robert H. Lurie Comprehensive Cancer Center, Northwestern University
More informationSummary CHAPTER 1. Introduction
Summary This thesis aims to evaluate the diagnostic work-up in postmenopausal women presenting with abnormal vaginal bleeding. The Society of Dutch Obstetrics and Gynaecology composed a guideline, which
More informationWOMEN S HEALTH SERVICES
WOMEN S HEALTH SERVICES Committed to enhancing the total well-being of women throughout their lives Knowledge-Powered Medicine 877-WSU-DOCS upgdocs.org/womenshealth WOMEN S HEALTH SERVICES UPG Women s
More informationSpecific Standards of Accreditation for Residency Programs in Gynecologic Reproductive Endocrinology & Infertility
Specific Standards of Accreditation for Residency Programs in Gynecologic Reproductive Endocrinology & Infertility 2011 INTRODUCTION A university wishing to have an accredited program in Gynecologic Reproductive
More informationUTERINE LEIOMYOSARCOMA. About Uterine leiomyosarcoma
UTERINE LEIOMYOSARCOMA Uterine Lms, Ulms Or Just Lms Rare uterine malignant tumour that arises from the smooth muscular part of the uterine wall. Diagnosis Female About Uterine leiomyosarcoma Uterine LMS
More informationFranchi Massimo Piergiuseppe. Policlinico Universitario G Rossi, Azienda Ospedaliera Universitaria Integrata di Verona Verona 2012
Curriculum Vitae Personal information First name(s) / Surname(s) Franchi Massimo Piergiuseppe Telephone(s) 0039 045 8122720 Fax(es) 0039 045 8123394 E-mail(s) Nationality massimo.franchi@univr.it Italian
More informationFocus on... Ovarian cancer. HE4 & ROMA score
Focus on... Ovarian cancer HE4 & ROMA score Ovarian cancer in the world* Accounting for around 4% of all cancers diagnosed in women The estimated World age-standardised incidence rate for the more developed
More informationREFERRAL GUIDELINES: GYNAECOLOGY
All patients referred to specialist clinics are assigned to a priority category based on their clinical need and related psychosocial factors. The examples given are indicative only and the clinician reviewing
More informationUnderstanding ovarian cancer An information sheet for women with ovarian cancer, their family and friends If you or someone you love has recently been diagnosed with ovarian cancer, you re sure to have
More informationUNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA DOCTORAL SCHOOL. PHD THESIS UNDESCENDED TESTICLE IN CHILD CLINICAL AND THERAPEUTIC ASPECTS - Abstract -
UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA DOCTORAL SCHOOL PHD THESIS UNDESCENDED TESTICLE IN CHILD CLINICAL AND THERAPEUTIC ASPECTS - Abstract - SCIENTIFIC COORDINATOR: Prof. Dr. Ion GEORGESCU PHD
More informationFemale Genital Tract Lab. Dr. Nisreen Abu Shahin Assistant Professor of Pathology University of Jordan
Female Genital Tract Lab Dr. Nisreen Abu Shahin Assistant Professor of Pathology University of Jordan Ovarian Pathology A 20-year-old female presented with vague left pelvic pain. Pelvic exam revealed
More informationCERVICAL CANCER FACTSHEET. What is cervical cancer?
CERVICAL CANCER FACTSHEET What is cervical cancer? ENGAGe is releasing a series of factsheets to raise awareness of gynaecological cancers and to support its network to work at a grassroots level. Take-up
More informationSee the latest estimates for new cases of ovarian cancer and deaths in the US and what research is currently being done.
About Ovarian Cancer Overview and Types If you have been diagnosed with ovarian cancer or are worried about it, you likely have a lot of questions. Learning some basics is a good place to start. What Is
More information2013 EDITORIAL REVISION 2017 VERSION 1.2
Specific Standards of Accreditation for Residency Programs in Gynecologic Reproductive Endocrinology and Infertility 2013 EDITORIAL REVISION 2017 VERSION 1.2 INTRODUCTION A university wishing to have an
More informationPHD THESIS STUDY ON THE USE OF THE PHARMACOLOGIC THERAPY WITH BUPROPION ON TOBACCO ABSTINENCE FOR SMOKERS WITH HIGH NICOTINE DEPENDENCE
THE UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA PHD THESIS STUDY ON THE USE OF THE PHARMACOLOGIC THERAPY WITH BUPROPION ON TOBACCO ABSTINENCE FOR SMOKERS WITH HIGH NICOTINE DEPENDENCE SCIENTIFIC COORDINATOR:
More informationUNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA FACULTY OF GENERAL MEDICINE DOCTOR S DEGREE THESIS ABSTRACT
UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA FACULTY OF GENERAL MEDICINE DOCTOR S DEGREE THESIS ABSTRACT CLINICAL, HISTOLOGICAL AND IMMUNOHISTOCHEMICAL STUDY IN A GROUP OF PATIENTS WITH BREAST CANCERS
More informationCLINICAL INVESTIGATION OF ORAL CONTRACEPTIVES
CLINICAL INVESTIGATION OF ORAL CONTRACEPTIVES Guideline Title Clinical Investigation of Oral Contraceptives Legislative basis Directive 75/318/EEC as amended Date of first adoption February 1987 Date of
More informationbleeding Studies naar de diagnostiek van endom triumcarcinoom bij vrouwen met postm nopauzaal bloedverlies. Studies on the
Studies on the diagnosis of endometria cancer in women with postmenopausal bleeding. Studies naar de diagnostiek va endometriumcarcinoom bij vrouwen m postmenopauzaal bloedverlies. Studies on the diagnosis
More informationOvarian Cancer. What you should know. making cancer less frightening by enlightening
Ovarian Cancer What you should know making cancer less frightening by enlightening ovarian cancer the facts Over 360 cases are diagnosed in Ireland annually It is the 6th most common cancer in women 4
More informationPassport to Health Preventing and Recognizing Gynecologic Cancers
Passport to Health Preventing and Recognizing Gynecologic Cancers Presented by: Obstetrician/Gynecologist Leigh Bauer, M.D. They can sneak up on you. 2 Gynecologic cancers, that is. Knowing the facts can
More informationUniversity of Medicine and Pharmacy Craiova. Faculty of Medicine. PhD THESIS ABSTRACT
University of Medicine and Pharmacy Craiova Faculty of Medicine PhD THESIS ABSTRACT STUDY OF THE CHANGES IN BONE MASS AND BONE METABOLISM MARKERS IN THYROTOXIC OSTEOPOROSIS. THERAPEUTIC IMPLICATIONS. Scientific
More informationShift your surgical ambition to surgical action
Dates: February 1-3, 2018 3th International Meeting ENDO-Dubai : Updates in Minimal Invasive surgery in Gynecology Shift your surgical ambition to surgical action AGENDA AT A GLANCE Thursday, February
More informationCleveland Clinic Laboratories. Anatomic Pathology
Cleveland Clinic Laboratories Anatomic Pathology OUR MISSION Cleveland Clinic Laboratories contributes to excellent patient care by providing high-quality, comprehensive laboratory testing and patient-focused
More informationPalm Beach Obstetrics & Gynecology, PA
Palm Beach Obstetrics & Gynecology, PA 4671 S. Congress Avenue, Lake Worth, FL 33461 561.434.0111 4631 N. Congress Avenue, Suite 102, West Palm Beach, FL 33407 Endometriosis The lining of the uterus is
More information6 Week Course Agenda. Today s Agenda. Ovarian Cancer: Risk Factors. Winning the War 11/30/2016 on Women s Cancer Gynecologic Cancer Prevention
6 Week Course Agenda Winning the War 11/30/2016 on Women s Cancer Gynecologic Cancer Prevention Lee-may Chen, MD Director, Division of Gynecologic Oncology Professor Department of Obstetrics, Gynecology
More informationEDUCATIONAL COMMENTARY CA 125. Learning Outcomes
EDUCATIONAL COMMENTARY CA 125 Learning Outcomes Upon completion of this exercise, participants will be able to: discuss the use of CA 125 levels in monitoring patients undergoing treatment for ovarian
More informationCorporate Medical Policy
Corporate Medical Policy Proteomics-based Testing Related to Ovarian Cancer File Name: Origination: Last CAP Review: Next CAP Review: Last Review: proteomics_based_testing_related_to_ovarian_cancer 7/2010
More informationClinical guideline Published: 27 April 2011 nice.org.uk/guidance/cg122
Ovarian cancer: recognition and initial management Clinical guideline Published: 27 April 2011 nice.org.uk/guidance/cg122 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationV. List the major objectives of the proposed minor and describe its chief features briefly.
I. School: Science Department: Psychology II. Proposed Minor: Health Psychology III. Related Major: Psychology IV. Projected Date of Implementation: Fall 2013 V. List the major objectives of the proposed
More informationSCREENING FOR OVARIAN CANCER: A SYSTEMATIC REVIEW 1998
SCREENING FOR OVARIAN CANCER: A SYSTEMATIC REVIEW 1998 EXECUTIVE SUMMARY Background Ovarian cancer is the seventh most common cancer in women world wide, and in England and Wales the mortality rate is
More informationTraining in Gynaecological Oncology LOG BOOK
Training in Gynaecological Oncology LOG BOOK Approved by The European Board and College of Obstetrics and Gynaecology (EBCOG) and the European Society of Gynaecological Oncology (ESGO) TO BE COMPLETED
More informationCURRICULUM VITAE PERSONAL INFORMATION
CURRICULUM VITAE PERSONAL INFORMATION Name: Mihai Raul Popescu Place of Birth : May 6 nd 1963, Craiova, Romania Marital status: Married, 2 child Address: Craiova 400421, street Barati, no.1 Telephone:
More informationreproductive organs. Malignant neoplasms. 4. Inflammatory disorders of female reproductive organs 2 5. Infertility. Family planning.
Thematic plan of lectures module iii. Diseases of female reproductive system. Family planning. Topic No of hours 1. Disturbances of menstrual function. Neuroendocrinological 2 syndromes in gynecology 1.
More informationGynecologic Cancers are many diseases. Speaker Disclosure: Gynecologic Cancer Care in the Age of Precision Medicine. Controversies in Women s Health
Gynecologic Cancer Care in the Age of Precision Medicine Gynecologic Cancers in the Age of Precision Medicine Controversies in Women s Health Lee-may Chen, MD Department of Obstetrics, Gynecology & Reproductive
More informationCURRICULUM VITAE. 7. Foreign languages known and the level of knowledge (certified or self-evaluation) Selfevaluation. Understanding Speaking Writing
MURESANU FIOR DAFIN CURRICULUM VITAE A. Personal data 1. Surname: Muresanu 2. First name: Fior Dafin 3. Date and place of birth: 14 March 1962, Prundul Bîrgaului, Romania 4. Citizenship: Romanian 6. Academic
More informationHIBBING COMMUNITY COLLEGE COURSE OUTLINE
HIBBING COMMUNITY COLLEGE COURSE OUTLINE COURSE NUMBER & TITLE: BIOL 2151: Human Physiology CREDITS: 4 (Lecture 3 / Lab 1) PREREQUISITES: Human Anatomy or Integrated Science recommended CATALOG DESCRIPTION:
More informationGynecological Cancers
Gynecological Cancers Outline Ovarian Cancer Uterine (Endometrial) Cancer Cervical Cancer Vulvar Cancer Vaginal Cancer Overian Cancer Ovarian cancer is cancer that forms in the tissue of the ovary and
More informationSarah Burton. Lead Gynae Oncology Nurse Specialist Cancer Care Cymru
Sarah Burton Lead Gynae Oncology Nurse Specialist Cancer Care Cymru Gynaecological Cancers Cervical Cancers Risk factors Presentation Early sexual activity Multiple sexual partners Smoking Human Papiloma
More informationCOMPARATIVE STUDY ON THE EVOLUTION AND DISEASES OF PATIENT PROGNOSIS WITH DILATED CARDIOMYOPATHY VERSUS NONISCHEMIC DOCTORATE THESIS.
UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA FACULTY OF MEDICINE COMPARATIVE STUDY ON THE EVOLUTION AND DISEASES OF PATIENT PROGNOSIS WITH DILATED CARDIOMYOPATHY VERSUS NONISCHEMIC DOCTORATE THESIS (summary)
More informationCore Module 13: Gynaecological Problems
Core Module 13: Gynaecological Problems Learning outcomes: To understand and demonstrate appropriate knowledge, skills and attitudes in relation to common gynaecological disorders To understand paediatric
More informationCorporate Medical Policy
Corporate Medical Policy Serum Biomarker Human Epididymis Protein 4 (HE4) File Name: Origination: Last CAP Review: Next CAP Review: Last Review: serum_biomarker_human_epididymis_protein_4_(he4) 1/2010
More informationReproductive Endocrinology and Infertility Rotation Objectives. Reproductive Endocrinology and Infertility Specialists
Reproductive Endocrinology and Infertility Rotation Objectives Reproductive Endocrinology and Infertility Specialists Terry O Grady M.D., FRCSC Sarah Healey M.D., FRCSC Deanna Murphy M.D., FRCSC Sean Murphy
More informationRealizing dreams booklet.indd 1 5/20/ :26:52 AM
Realizing dreams. 18891booklet.indd 1 5/20/2010 11:26:52 AM The Journey To Parenthood The first Gator Baby was born in 1988 through the in vitro fertilization program at the University of Florida. Since
More informationI have no financial interests in any product I will discuss today.
Cervical Cancer Prevention: 2012 and Beyond George F. Sawaya, MD Professor Department of Obstetrics, Gynecology and Reproductive Sciences Department of Epidemiology and Biostatistics University of California,
More informationSCREENING FOR OVARIAN CANCER DR MACİT ARVAS
SCREENING FOR OVARIAN CANCER DR MACİT ARVAS Ovarian cancer is the leading cause of death from gynecologic malignancy In 2008, ovarian cancer was the seventh common cancer in women worldwide There were
More informationOvaries: In Sickness and Health. Mr N Pisal Consultant Gynaecologist The Portland Hospital
Ovaries: In Sickness and Health Mr N Pisal Consultant Gynaecologist The Portland Hospital Topics for discussion How to assess ovarian function? AMH PCOS Ovarian pain Ovarian cysts Ovarian screening Menopause
More informationA Festival of Health, Head to Toe. from Head to Toe.
Jessop Wing www.sth.nhs.uk/our-hospitals/jessop-wing A Festival of Health, A Festival of Health from Head to Toe. from Head to Toe. Free activities, talks and events open to everyone 16 24 April 2016 www.sheffield.ac.uk/life
More informationGynecologic Cancers are many diseases. Gynecologic Cancers in the Age of Precision Medicine Advances in Internal Medicine. Speaker Disclosure:
Gynecologic Cancer Care in the Age of Precision Medicine Gynecologic Cancers in the Age of Precision Medicine Advances in Internal Medicine Lee-may Chen, MD Department of Obstetrics, Gynecology & Reproductive
More informationISPUB.COM. Breast Angiosarcoma. C Lilaia, F Pereira, S André, B Cabrita INTRODUCTION CASE REPORT
ISPUB.COM The Internet Journal of Gynecology and Obstetrics Volume 6 Number 2 C Lilaia, F Pereira, S André, B Cabrita Citation C Lilaia, F Pereira, S André, B Cabrita.. The Internet Journal of Gynecology
More informationNeurofibromatosis (NF) Center
Washington University Neurofibromatosis (NF) Center THE NF CENTER: EXCEPTIONAL CARE THROUGH GROUNDBREAKING RESEARCH An international leader in research and treatment of neurofibromatosis (NF), the Washington
More informationEvaluation of the Infertile Couple
Overview and Definition Infertility is defined as the inability of a couple to fall pregnant after one year of unprotected intercourse. Infertility is a very common condition as in any given year about
More informationAdnexal Masses in Menopausal Women Surgery or Surveillance?
Adnexal Masses in Menopausal Women Surgery or Surveillance? FREDTALK IDEASWORTHSPREADING Disclosure I am a member of Vermillion s Speakers Bureau I am NOT a paid consultant for Vermillion Inc. nor do I
More information12 th European Congress on Menopause and Andropause
15 17 may 2019 berlin 2019 12 th European Congress on Menopause and Andropause 15 17.05.2019 Berlin, Germany Managing Midlife Health and Beyond in the Era of e-medicine 2019.emas-online.org #EMAS2019 Welcome
More informationWHY INVESTIGATE FOR INFERTILITY
WHY INVESTIGATE FOR INFERTILITY Intrauterine Insemination 1 About this booklet This series of booklets has been developed and written with the support of leading fertility clinics across Australia, and
More informationEuropass Curriculum Vitae
Europass Curriculum Vitae Personal information First name(s) / Surname(s) Address Via Gattamelata 64 35128 Padova Telephone(s) +39 049.8215953/5910 E-mail(s) vittorina.zagonel@iov.veneto.it Nationality
More informationSOCIAL SCIENCES AND HUMANITIES CENTER BACHELOR S DEGREE IN PSYCHOLOGY
OBJECTIVE: To shape professionals in psychology with knowledge of basic psychological processes as well as the biological, anthropological, social, and cultural basis of human behavior with skills to accurately
More informationAsk the Experts Obstetrics & Gynecology
1 Management of the Adnexal Mass James H. Liu, MD, and Kristine M. Zanotti, MD June 2011 Volume 117 Issue 6 Pages 1413 28 Click Here to Read the Full Article Questions written by: Rini Banerjee Ratan,
More informationThe Adnexal Mass. Handout NCUS 3/18/2017 Suzanne Dixon, MD
The Adnexal Mass Handout NCUS 3/18/2017 Suzanne Dixon, MD Objectives: Pelvic mass differential Characteristics of the normal ovary Standard terminology for ovarian masses Benign vs. malignant features
More informationBRCA mutation carrier patient: How to manage?
BRCA mutation carrier patient: How to manage? Clinical Case Presentation Katarzyna Sosińska-Mielcarek Department of Oncology and Radiotherapy University Clinical Center Gdansk, Poland esmo.org DISCLOSURE
More informationWhat is endometrial cancer?
Uterine cancer What is endometrial cancer? Endometrial cancer is the growth of abnormal cells in the lining of the uterus. The lining is called the endometrium. Endometrial cancer usually occurs in women
More informationOvarian cancer experience from a Romanian regional center: preliminary results
Human & Veterinary Medicine International Journal of the Bioflux Society OPEN ACCESS Research Article Ovarian cancer experience from a Romanian regional center: preliminary results 1 Anita-Roxana Maxim,
More informationIntroduction to GYN Specialties
Outline Introduction to GYN Specialties Gynecologic Oncology* Female Pelvic Medicine and Reconstructive Surgery* Reproductive Endocrinology and Infertility* Pediatric and Adolescent Gynecology** Family
More informationUterine sarcoma. Information for patients Gynaecology
Uterine sarcoma Information for patients Gynaecology page 2 of 12 This leaflet is intended to offer you support and information at a very difficult and stressful time in your life. To be told that you
More informationCLINICAL PRESENTATION AND RADIOLOGY QUIZ QUESTION
Donald L. Renfrew, MD Radiology Associates of the Fox Valley, 333 N. Commercial Street, Suite 100, Neenah, WI 54956 2/12/2011 Radiology Quiz of the Week # 7 Page 1 CLINICAL PRESENTATION AND RADIOLOGY QUIZ
More informationHereditary Breast and Ovarian Cancer (HBOC) Information for individuals and families
Hereditary Breast and Ovarian Cancer (HBOC) Information for individuals and families What is Hereditary Breast and Ovarian Cancer (HBOC)? Hereditary Breast and Ovarian Cancer is a genetic condition which
More informationCervical Cancer. Introduction Cervical cancer is a very common cancer. Nearly one half million cases are diagnosed worldwide each year.
Cervical Cancer Introduction Cervical cancer is a very common cancer. Nearly one half million cases are diagnosed worldwide each year. Most cases of cervical cancer can be prevented by getting regular
More informationESSO ACCREDITED TRAINING FELLOWSHIP IN BREAST SURGERY
ESSO ACCREDITED TRAINING FELLOWSHIP IN BREAST SURGERY 2 TABLE OF CONTENTS 1. BACKGROUND 2. PROGRAM REQUIREMENTS 3. TRAINING OBJECTIVES (Annex 1) 4. TRAINING INSTITUTTIONS (Annex 2) 5. CANDIDATES 6. APPLICATION
More informationSenior researcher III/ Head of Research Psychiatry Laboratory Alexandru Obregia Clinical Hospital of Psychiatry
Europass Curriculum Vitae Personal information First name(s) / Surname(s) Magdalena Budisteanu Address(es) 1 Veronica Micle St., Bucharest, Romania Telephone(s) 0040213349068 Mobile: 0040722929091 Fax(es)
More informationGynecology Oncology Rotation
McGill University Obstetrics and Gynecology Residency Program Goals and Objectives Gynecology Oncology Rotation Overview Goal The primary goal of the resident s Gynecology Oncology rotation of 4 weeks
More informationSUMMARY. Keywords: quail, Coturnix japonica, morphology, ovary, oviduct, neurotrophins, immunohistochemistry
SUMMARY Keywords: quail, Coturnix japonica, morphology, ovary, oviduct, neurotrophins, immunohistochemistry Studies on the development of biological systems have expanded using animal models, always to
More informationOur business is improving the quality of primary care and creating opportunity for primary care to develop its services.
BICS Our Business Our business is improving the quality of primary care and creating opportunity for primary care to develop its services. Quality of experience care designed around individuals and subpopulations.
More informationTISSUE TUMOR MARKER EXPRESSION IN
TISSUE TUMOR MARKER EXPRESSION IN NORMAL CERVICAL TISSUE AND IN CERVICAL INTRAEPITHELIAL NEOPLASIA, FOR WOMEN WHO ARE AT HIGH RISK OF HPV (HUMAN PAPILLOMA VIRUS INFECTION). Raghad Samir MD PhD Verksamhet
More informationEndometrial line thickness in different conditions.
Endometrial line thickness in different conditions 1 Endometrial thickens in response to Rising estrogen levels during the menstrual cycle and then shedding endometrial at the times of menses 2 The thickens
More informationAmerican Journal of Oral Medicine and Radiology
American Journal of Oral Medicine and Radiology e - ISSN - XXXX-XXXX ISSN - 2394-7721 Journal homepage: www.mcmed.us/journal/ajomr ULTRASONOGRAPHIC EVALUATION OF ADNEXAL MASSES Nageswar Rao* Professor,
More informationPrevention, Diagnosis and Treatment of Gynecologic Cancers
Prevention, Diagnosis and Treatment of Gynecologic Cancers Jubilee Brown MD and Pamela T. Soliman MD, MPH Department of Gynecologic Oncology and Reproductive Medicine University of Texas MD Anderson Cancer
More informationPOST - DOCTORAL FELLOWSHIP PROGRAMME IN REPRODUCTIVE MEDICINE. Anatomy : Male and Female genital tract
POST - DOCTORAL FELLOWSHIP PROGRAMME IN REPRODUCTIVE MEDICINE DURATION OF THE COURSE : TWO YEARS Detailed syllabus: Part 1 Basic Sciences: Anatomy : Male and Female genital tract Physiology Endocrinology
More informationAbout PCOS. About PCOS
About PCOS About PCOS Polycystic Ovarian Syndrome (PCOS) is the most common hormonal reproductive problem in women of childbearing age. It can affect a woman s menstrual cycle, fertility, hormones, insulin
More informationFast Facts: Ovarian Cancer
Fast Facts Fast Facts: Ovarian Cancer Christina Fotopoulou MD PhD Consultant Gynaecological Oncologist Queen Charlotte s and Chelsea Hospital London, UK Thomas J Herzog MD Professor of Obstetrics and Gynecology
More information